The role of the pharmacist in the care of patients with cardiovascular diseases

Świeczkowski, Damian; Merks, Piotr; Gruchała, Marcin; Jaguszewski, Miłosz

doi:10.5603/kp.a2016.0136

Cited by 14 publications

(12 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to medication dispensing, the pharmacist can provide more direct interventions (eg, medication education and disease management), as a support to the physician’s action, in order to improve medication adherence, to achieve the goals of desired therapeutic outcomes and to improve safe medication use and humanistic control. 2 The direct pharmacist’s intervention in patients’ care, in alternative to conventional approach, has proved to favourably affect therapeutic and safety outcomes in different diseases or conditions including diabetes, dyslipidaemia, arterial hypertension, obesity, asthma or chronic obstructive pulmonary disease, infective diseases (including influenza immunisation), psychiatric conditions and osteoporosis prevention. 3–5 A recent overview of systematic reviews has documented a positive impact on patients’ outcomes (blood pressure and haemoglobin A1c reduction) of clinical pharmacy services targeting specific cardiovascular conditions, such as hypertension or diabetes mellitus.…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases

2018

View full text Add to dashboard Cite

The pharmacist may play a relevant role in primary and secondary prevention of cardiovascular diseases, mainly through patient education and counselling, drug safety management, medication review, monitoring and reconciliation, detection and control of specific cardiovascular risk factors (eg, blood pressure, blood glucose, serum lipids) and clinical outcomes. Systematic reviews of randomised controlled and observational studies have documented an improved control of hypertension, dyslipidaemia or diabetes, smoking cessation and reduced hospitalisation in patients with heart failure, following a pharmacist’s intervention. Limited proof for effectiveness is available for humanistic (patient satisfaction, adherence and knowledge) and economic outcomes. A multidisciplinary approach, including medical input plus a pharmacist, specialist nurse or both, and a greater involvement of community rather than hospital pharmacists, seems to represent the most efficient and modern healthcare delivery model. However, further well-designed research is demanded in order to quantitatively and qualitatively evaluate the impact of pharmacist’s interventions on cardiovascular disease and to identify specific areas of impact of collaborative practice. Such research should particularly focus on the demonstration of a sensitivity to community pharmacist’s intervention. Since pharmacy services are easily accessible and widely distributed in the community setting, a maximum benefit should be expected from interventions provided in this context.

show abstract

Section: Introductionmentioning

confidence: 99%

Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases

2018

View full text Add to dashboard Cite

show abstract

“…The need for PC implementation in Poland has been previously noted by other Polish researchers [ 10 , 11 , 17 , 18 ], and by the National Section of Pharmaceutical Care of the Polish Pharmaceutical Society which presented their own proposal of state-of-the-art pharmaceutical care development in Poland in 2016 [ 19 ] addressing the areas for improvement and issues limiting provision of PC in Poland in detail.…”

Section: Discussionmentioning

confidence: 99%

“…The popularization of interprofessional collaboration should be launched in concert with the undergraduate training and subsequently continued in the postgraduate education. The future should bring enhanced efforts of all relevant stakeholders in the dissemination of the concept of interprofessional collaboration, predominantly from the practical point of view [ 10 ]. To effectively implement the cognitive services, legal-related issues should be resolved, particularly those related to medical information [ 42 ].…”

Section: Discussionmentioning

confidence: 99%

“…Hence, the services should be reimbursed from public sources. Otherwise, the roll-out of these services will be rather marginal [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

“…There is also a notable trend, however, to expand the range of pharmacy services by preventive healthcare and instructing patient on the proper use of drugs, as well as extending their knowledge about their disease and its impact on the patient’s life. In practice, therefore, pharmaceutical care, understood as a broad, holistic approach, is implemented through a number of services/pharmaceutical interventions [ 10 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

A survey of pharmacists' knowledge, attitudes and barriers in pharmaceutical care concept in Poland

et al. 2021

View full text Add to dashboard Cite

Background The major goals of pharmaceutical care (PC) are to improve the patient’s quality of life and ensure safety of pharmacotherapy. Inclusion of a pharmacist in the multidisciplinary team caring for the patient and integration of state-of-the-art pharmaceutical services with medical care and nursing are some of the most important challenges that the health care system in Poland is facing. Objectives To evaluate the pharmacists attitudes towards practice in, and knowledge of PC in Poland and to identify the barriers in PC provision. Methods The study was designed as a multicenter study, conducted among Polish pharmacists. Random sampling technique was employed to select the study group. Face-to-face questionnaire method was used to interview the pharmacists, upon obtaining their prior verbal consent to participate in the study. The study was conducted between January 2017 and September 2019. Results Only 15% of the pharmacists have ever attended a training on PC. 72% believed PC provision was necessary to ensure pharmacotherapy safety. Only 63% of the pharmacists believed that preventing and solving health-related and drug therapy problems for patients were their responsibilities. The main reason for non-provision of PC by the pharmacists was the lack of time for such activities, lack of legal regulations, lack of organizational facilities. Conclusion This study indicates that implementation of PC is expected in Poland. Educational programs in this respect are urgently needed. PC provision should be included in the curricula of academic pharmaceutical courses.

show abstract